Additional information
Off white Powder
546-57-6
ACI-052309
(1S,4S,5R,8R,9S,10S,11R,12R,14R)-5-ethyl-9-hydroxy-2,4,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopyranosyl]oxy]-6,15,16-trioxatricyclo[10.2.1.11,4]hexadec-2-en-7-one (Erythralosamine),
(1S,4S,5R,8R,9S,10S,11R,12R,14R)-5-ethyl-9-hydroxy-2,4,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopyranosyl]oxy]-6,15,16-trioxatricyclo[10.2.1.11,4]hexadec-2-en-7-one (erythralosamine),
199.2-201.1°C
C29H49NO8
539.7
Ambient
2-8°C
3-O-De(2,6-dideoxy-3-C-methyl-3-O-methyl-?-L-ribo-hexopyranosyl)-10,11-didehydro-9-deoxo-6,11,12-trideoxy-6,9:9,12-diepoxy-erythromycin; 6,15,16-Trioxatricyclo[10.2.1.11,4]hexadecane Erythromycin Derivative
Antibiotic





![N-ETHYL AZILSARTAN MEDOXOMIL (25 mg) ((5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate)](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)